Openbookopenbook
Equity
TCMD
+0.0 · +0.00%
USD · NASDAQ

Tactile Systems Technology Inc(TCMD) Stock Analysis | Healthcare

USD --+0.00%
Reward72High
Risk30Moderate
75%Data
Quality Compounder
Market Cap:524.63M
ⓘ
Reward Rating
72
High
Reward Assessment
75% data coverage
Top 25% of stocksView factors
ⓘ
Risk Rating
30
Moderate
Risk Assessment

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on TCMD to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for TCMD, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $38.25.

What is Tactile Systems Technology Inc?

, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.

TCMD · Verdict

Strong reward · low risk

TCMD scores well on balance sheet and cash flow with no major weaknesses flagged in the model.

Based on 88% data coverage

TCMD · Verdict

What’s working & what to watch

Strengths 5

  • Balance sheet99/100

    Interest covered 31.2×

  • Cash flow85/100

    12% free-cash-flow margin

  • Growth82/100

    Revenue +10.1% CAGR

  • Valuation78/100

    P/E 19.1× · PEG 17.79

  • Profitability73/100

    6% net margin · 12% ROE

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Tactile Systems Technology Inc?

, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 524.63M, and a P/E ratio of 21.6x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: High (72)

The scoring profile indicates a strong reward potential, driven primarily by growth and valuation. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.

CALZFSmall Cap / 511M market cap
PolyNovo Limited
Compare
NPCESmall Cap / 507M market cap
Neuropace Inc
Compare
IOBCFSmall Cap / 558M market cap
Ion Beam Applications SA
Compare
Company Information
SectorHealthcare
IndustryMedical Devices
Market Cap524.63M
P/E Ratio21.6449
Dividend YieldN/A
Beta0.822
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
0
0
3-6months
0
0
6-9months
755,276 shares
$1.6M
0
9-12months
0
0
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.